Fennec Pharmaceuticals (FENC) Shareholder's Equity (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 889.67% |
| Sep 30, 2025 | 39.81% |
| Jun 30, 2025 | -26.92% |
| Mar 31, 2025 | -0.14% |
| Dec 31, 2024 | -13.56% |
| Sep 30, 2024 | -281.06% |
| Jun 30, 2024 | -145.02% |
| Mar 31, 2024 | 125.93% |
| Dec 31, 2023 | -10.36% |
| Sep 30, 2023 | -8.27% |
| Jun 30, 2023 | -32.54% |
| Mar 31, 2023 | -185.68% |
| Dec 31, 2022 | -191.68% |
| Sep 30, 2022 | -67.19% |
| Jun 30, 2022 | -31.80% |
| Mar 31, 2022 | -20.59% |
| Dec 31, 2021 | -17.05% |
| Sep 30, 2021 | -14.67% |
| Jun 30, 2021 | -10.64% |
| Mar 31, 2021 | -14.23% |
| Dec 31, 2020 | -6.78% |
| Sep 30, 2020 | -13.68% |
| Jun 30, 2020 | 326.97% |
| Mar 31, 2020 | -28.75% |
| Dec 31, 2019 | -20.84% |
| Sep 30, 2019 | -8.95% |
| Jun 30, 2019 | -14.21% |
| Mar 31, 2019 | -9.89% |
| Dec 31, 2018 | -6.76% |
| Sep 30, 2018 | -8.04% |
| Jun 30, 2018 | -3.14% |
| Mar 31, 2018 | -4.09% |
| Dec 31, 2017 | 202.07% |
| Sep 30, 2017 | -8.48% |
| Jun 30, 2017 | 238.31% |
| Mar 31, 2017 | -19.86% |
| Dec 31, 2016 | -15.40% |
| Sep 30, 2016 | -9.31% |
| Jun 30, 2016 | 1,814.81% |
| Mar 31, 2016 | -55.66% |
| Dec 31, 2015 | -46.22% |
| Sep 30, 2015 | -8.36% |
| Jun 30, 2015 | 34.62% |
| Mar 31, 2015 | 34.75% |
| Dec 31, 2014 | 118.99% |
| Sep 30, 2014 | 30.70% |
| Jun 30, 2014 | -7.48% |
| Mar 31, 2014 | -197.87% |
| Dec 31, 2013 | 64.74% |
| Sep 30, 2013 | -69.91% |
| Jun 30, 2013 | 73.20% |
| Mar 31, 2013 | -82.87% |
| Dec 31, 2012 | -486.06% |
| Sep 30, 2012 | -37.21% |
| Jun 30, 2012 | -21.19% |
| Mar 31, 2012 | 2,262.50% |
| Dec 31, 2011 | 96.73% |
| Sep 30, 2011 | -436.55% |
| Jun 30, 2011 | -141.70% |
| Mar 31, 2011 | 94.25% |